Ticker,Title,Link
EYEN,Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer,9/3/2024 1:00:00 PM
EYEN,Eyenovia Announces Closing of Public Offering,8/23/2024 5:42:23 PM
EYEN,Eyenovia announces pricing of $5.14M public offering,8/21/2024 6:18:13 PM
EYEN,"Eyenovia, Inc. Announces Proposed Public Offering",8/20/2024 11:09:50 PM
EYEN,Eyenovia to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference,8/13/2024 1:00:00 PM
EYEN,Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update,8/12/2024 10:05:00 PM
EYEN,"Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th",8/8/2024 1:00:00 PM
EYEN,Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S.,8/7/2024 11:11:42 PM
EYEN,Eyenovia To Collaborate With SGN Nanopharma To Develop Treatment For Dry Eye Disease ,7/30/2024 4:52:37 PM
EYEN,Eyenovia’s Market Growth and Diversification: A Buy Rating Overview,7/24/2024 10:15:44 AM
EYEN,Eyenovia Collaborates With Senju Pharma For Potential Treatment For Chronic Dry Eye ,7/23/2024 2:35:30 PM
EYEN,Eyenovia Announces Pricing of $5M Registered Direct Offering,6/28/2024 2:00:14 PM
EYEN,Peek Behind the Curtain: 7 Penny Stocks With Heavy Insider Buying,5/23/2024 10:00:00 AM
EYEN,All You Need to Know About Eyenovia Rating Upgrade to Buy,5/21/2024 10:01:40 PM
EYEN,"SYTA, DATS and CYN among mid-day movers",5/16/2024 4:59:34 PM
EYEN,"Eyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III Program and its Two FDA Approved Commercial Products, Mydcombi and Clobetasol",5/15/2024 10:01:00 PM
EYEN,"Eyenovia to Report First Quarter 2024 Results on Wednesday, May 15th",5/14/2024 1:00:00 PM
EYEN,Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi™ and Clobetasol Propionate Ophthalmic Suspension,4/25/2024 1:00:00 PM
EYEN,Eyenovia Announces Updated Strategy and Corporate Priorities to Focus on Shareholder Value Generation and Immediate Commercial Opportunities,4/8/2024 1:00:00 PM
EYEN,Eyenovia to Feature its Suite of Commercial Products and the Optejet Dispenser at Upcoming National Eyecare Meetings,4/3/2024 1:00:00 PM
EYEN,Over $2M Bet On NextNav? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying,3/21/2024 11:45:35 AM
EYEN,"OTRK, STRC and APM among mid-day movers",3/19/2024 4:48:26 PM
EYEN,Eyenovia Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update,3/18/2024 9:05:00 PM
EYEN,Notable earnings after Monday's close,3/17/2024 9:35:21 PM
EYEN,NovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare Professionals,3/13/2024 12:00:00 PM
EYEN,"Eyenovia to Report Fourth Quarter 2023 Results and Provide Business Update on Monday, March 18th",3/11/2024 12:00:00 PM
EYEN,Eyenovia’s Strategic Expansion: Dual Product Offering Enhances Market Position,3/6/2024 11:37:35 AM
EYEN,Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session,3/5/2024 7:11:48 PM
EYEN,"MSTR, NNOX and CAN are among pre market gainers",2/28/2024 1:29:21 PM
EYEN,FDA approves Eyenovia manufacturing facility in Redwood City,2/13/2024 6:02:35 PM
EYEN,Eyenovia Re-Acquires Development and Commercialization Rights to MicroPine in the U.S. and Canada,1/16/2024 1:00:00 PM
EYEN,7 Promising Penny Stocks With the Potential to Defy Expectations,12/15/2023 1:17:05 PM
EYEN,"Analysts’ Top Healthcare Picks: Arcellx Inc (ACLX), Clearside Biomedical (CLSD)",11/14/2023 11:30:59 AM
EYEN,Eyenovia Reports Third Quarter 2023 Financial Results and Provides Business Update,11/13/2023 10:05:00 PM
EYEN,"Eyenovia to Report Third Quarter 2023 Results on Monday, November 13",11/6/2023 2:00:00 PM
EYEN,Eyenovia Announces FDA Approval of Coastline International as Contract Manufacturer to Initiate Mydcombi Commercial Production,11/2/2023 12:00:00 PM
EYEN,Eyenovia's Stock Is Soaring Today - Here's Why,11/1/2023 8:05:16 PM
EYEN,Why Biophytis Shares Are Trading Higher By Over 12%: Here Are 20 Stocks Moving Premarket,10/30/2023 1:44:56 PM
EYEN,Eyenovia to Present Data on Preservative-Free Microbial Integrity of the Optejet®,10/9/2023 1:00:00 PM
EYEN,Eyenovia to Participate in Panel Discussion at Cantor Global Healthcare Conference,9/21/2023 2:00:00 PM
EYEN,Eyenovia to Present at Upcoming H.C. Wainwright 25th Annual Global Investment Conference,9/7/2023 2:00:00 PM
EYEN,"IDEX, RCRT and BRSH among pre-market losers",8/25/2023 12:30:50 PM
EYEN,H.C. Wainwright Keeps Their Buy Rating on Eyenovia (EYEN),8/18/2023 10:15:22 AM
EYEN,Formosa Pharma: Eyenovia Obtains U.S. Rights For Commercialization Of APP13007 ,8/16/2023 12:14:44 PM
EYEN,H.C. Wainwright Remains a Buy on Eyenovia (EYEN),8/11/2023 10:35:17 AM
EYEN,Eyenovia Reports Second Quarter 2023 Financial Results and Provides Business Update,8/10/2023 10:05:00 PM
EYEN,Eyenovia announces addition to Russell 2000 and Russell 3000 indexes,6/26/2023 2:20:43 PM
EYEN,Eyenovia GAAP EPS of -$0.15 beats by $0.04,5/11/2023 8:18:31 PM
EYEN,Notable earnings after Thursday's close,5/10/2023 9:35:55 PM
EYEN,"Analysts Are Bullish on Top Healthcare Stocks: Aptose Biosciences (APTO), Eyenovia (EYEN)",5/9/2023 4:20:08 PM
EYEN,Eyenovia's Mydcombi for mydriasis approved by FDA,5/8/2023 12:33:53 PM
EYEN,"Pfizer, GSK, AbbVie among pharmas set to rise with May catalysts",4/29/2023 8:00:00 PM
EYEN,"Analysts Offer Insights on Healthcare Companies: GlaxoSmithKline (GSK), Karyopharm Therapeutics (KPTI) and Eyenovia (EYEN)",4/19/2023 10:20:10 AM
EYEN,H.C. Wainwright Remains a Buy on Eyenovia (EYEN),4/3/2023 10:15:27 AM
EYEN,Eyenovia GAAP EPS of -$0.17 beats by $0.03,3/30/2023 8:23:05 PM
EYEN,Notable earnings after Thursday's close,3/29/2023 9:35:59 PM
EYEN,Formosa Pharmaceuticals enters development collaboration pact with Eyenovia,2/15/2023 9:01:45 AM
EYEN,Eyenovia rises on positive data from Optejet delivery technology trial,1/12/2023 2:16:27 PM
EYEN,Eyenovia stock rises on getting FDA review for MydCombi for pupil dilation,12/13/2022 2:55:41 PM
EYEN,Eyenovia to Present at Upcoming BTIG Ophthalmology Day,11/23/2022 10:05:00 PM
EYEN,H.C. Wainwright Sticks to Its Buy Rating for Eyenovia (EYEN),11/11/2022 11:25:58 AM
EYEN,Eyenovia Reports Third Quarter 2022 Financial Results and Provides Business Update,11/10/2022 10:05:00 PM
EYEN,Notable earnings after Thursday's close,11/9/2022 10:35:34 PM
EYEN,"Eyenovia to Report Third Quarter 2022 Results on Thursday, November 10",11/3/2022 1:00:00 PM
EYEN,"Analysts Are Bullish on These Healthcare Stocks: Revance Therapeutics (RVNC), Eyenovia (EYEN)",10/25/2022 6:50:21 PM
EYEN,Eyenovia to Present at the American Academy of Optometry’s Annual Meeting,10/21/2022 2:00:00 PM
EYEN,Eyenovia Announces Positive Results from VISION-2 Phase 3 Study of MicroLine as a Potential On-Demand Treatment for Presbyopia,10/20/2022 2:00:00 PM
EYEN,"Pre-market Movers: INPX, GEHI, HAPP, MPTI, ADEA… ",10/17/2022 1:18:17 PM
EYEN,HC Wainwright Initiates This Eye-Focused Stock With Almost 400% Upside,10/5/2022 8:50:20 PM
EYEN,"Eyenovia Announces Planned Retirement of Lead Independent Director Ken Lee, Jr.",9/30/2022 2:00:00 PM
EYEN,Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday,9/9/2022 10:14:31 AM
EYEN,Eyenovia to Present at Upcoming Healthcare Conferences,9/7/2022 2:00:00 PM
EYEN,Eyenovia to Participate in Multiple Medical Meetings in September,9/6/2022 2:00:00 PM
EYEN,Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday,9/2/2022 11:29:23 AM
EYEN,Eyenovia Reports Second Quarter 2022 Financial Results,8/10/2022 10:05:00 PM
EYEN,Eyenovia Q2 2022 Earnings Preview,8/9/2022 9:35:54 PM
EYEN,"Eyenovia to Report Second Quarter 2022 Results on Wednesday, August 10",8/4/2022 2:00:00 PM
EYEN,Eyenovia Announces Appointment of Ophthalmic Industry Veteran Michael Rowe as  Chief Executive Officer and Board Member,7/27/2022 2:00:00 PM
EYEN,Eyenovia Provides Manufacturing Update and Announces Appointment of Bren Kern as  SVP of Manufacturing and Operations,7/18/2022 2:00:00 PM
EYEN,Eyenovia Announces Appointments of Dr. Ellen Strahlman and Dr. Ram Palanki as New and Independent Members of its Board of Directors,7/7/2022 2:00:00 PM
EYEN,Eyenovia Strategic Partner Arctic Vision Enrolls First Patient in Phase III Clinical Trial of ARVN003 (MicroLine) for Presbyopia in China,7/6/2022 2:00:00 PM
EYEN,UPDATE: Eyenovia Announces Virtual 2022 Annual Meeting of Stockholders,6/9/2022 4:09:12 PM
EYEN,Eyenovia Announces Planned Chief Executive Officer Transition,6/7/2022 2:00:00 PM
EYEN,Eyenovia Reports First Quarter 2022 Financial Results,5/12/2022 10:05:00 PM
EYEN,Eyenovia Q1 2022 Earnings Preview,5/11/2022 9:35:57 PM
EYEN,"Eyenovia to Report First Quarter 2022 Results on Thursday, May 12",5/5/2022 2:00:00 PM
EYEN,"Eyenovia CEO, CMO and Chairman Dr. Sean Ianchulev to Present at Eyecelerator @ American Society of Cataract and Refractive Surgery (ASCRS) 2022",4/20/2022 2:00:00 PM
EYEN,Eyenovia Announces Poster Presentation at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting,4/19/2022 2:00:00 PM
EYEN,Eyenovia Reports Fourth Quarter and Full Year 2021 Financial Results,3/28/2022 10:05:00 PM
EYEN,Notable earnings after Monday's close,3/27/2022 9:35:10 PM
EYEN,"Eyenovia to Report Fourth Quarter and Full Year 2021 Results on Monday, March 28",3/21/2022 1:00:00 PM
EYEN,Eyenovia Announces Positive Study Results Demonstrating that its Optejet® Delivery Technology Reduces Conjunctival Cell Toxicity from Preserved Ophthalmic Solutions to a Level Comparable with...,3/15/2022 1:00:00 PM
EYEN,"The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan",3/4/2022 1:38:12 PM
EYEN,Eyenovia rises 6% following FDA meeting linked to MydCombi NDA refiling,2/8/2022 6:31:29 PM
EYEN,Eyenovia Announces Changes to Board of Directors,2/7/2022 2:30:00 PM
EYEN,Eyenovia Reports Third Quarter 2021 Financial Results,11/10/2021 10:05:00 PM
EYEN,Eyenovia to Participate in Myopia Panel Discussion at the Eyecelerator@AAO 2021 Meeting,11/8/2021 2:00:00 PM
EYEN,"CORRECTING AND REPLACING: Eyenovia to Report Third Quarter 2021 Results on Wednesday, November 10",11/5/2021 8:25:02 PM
EYEN,"Eyenovia to Report Third Quarter 2021 Results on Thursday, November 11",11/4/2021 9:05:00 PM
EYEN,Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates,11/2/2021 3:30:16 PM
EYEN,"The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline",10/31/2021 7:23:54 PM
EYEN,"DGLY, PHUN and BPTH among pre market gainers",10/27/2021 12:31:17 PM
EYEN,56 Biggest Movers From Yesterday,10/26/2021 11:27:21 AM
EYEN,Mid-Afternoon Market Update: Nasdaq Jumps 150 Points; Bakkt Holdings Shares Spike Higher,10/25/2021 8:31:01 PM
EYEN,"The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More",10/24/2021 5:45:47 PM
EYEN,"Catalyst watch for next week: Tech giants report, eyes on Digital World Acquisition, events for Datadog, Facebook & HPE",10/22/2021 7:00:19 PM
EYEN,Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates,10/1/2021 8:17:08 PM
EYEN,Biotech Stocks Facing FDA Decision In October 2021 ,9/30/2021 8:58:51 AM
EYEN,Eyenovia Reports Second Quarter 2021 Financial Results,8/11/2021 10:05:00 PM
EYEN,"The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight",8/8/2021 4:11:24 PM
EYEN,"Eyenovia to Report Second Quarter 2021 Results on Wednesday, August 11",8/4/2021 2:00:00 PM
EYEN,Eyenovia to Participate in Two Upcoming Investor Conferences,7/7/2021 10:01:00 PM
EYEN,"Eyenovia highlights Recent Progress in Three Phase 3 Programs, NDA Review Progress and Licensing Agreements Totaling up to $100 Million in Potential Pre-Commercial Revenue",6/15/2021 2:00:00 PM
EYEN,Stock Alert: Eyenovia Up 10% On Positive Late-stage Study Results Of Its MicroLine ,5/25/2021 4:12:32 PM
EYEN,Eyenovia Reports First Quarter 2021 Financial Results,5/12/2021 10:05:00 PM
EYEN,Eyenovia Announces New $25 Million Credit Facility with Silicon Valley Bank,5/10/2021 2:30:00 PM
EYEN,"The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings",5/9/2021 4:20:33 PM
EYEN,"Eyenovia to Report First Quarter 2021 Results on Wednesday, May 12",5/5/2021 2:00:00 PM
EYEN,Eyenovia Reports Fourth Quarter and Full Year 2020 Financial Results,3/25/2021 9:05:00 PM
EYEN,"FDA Decisions For Pfizer, Eli Lilly And Bluebird Bio, Bristol-Meyers Squibb, Plus New Data And Earnings",3/20/2021 2:52:32 PM
EYEN,"Eyenovia to Report Fourth Quarter and Full Year 2020 Results on Thursday, March 25",3/18/2021 1:00:00 PM
EYEN,Eyenovia to Participate in the 33rd Annual Roth Conference,3/10/2021 2:00:00 PM
EYEN,61 Biggest Movers From Yesterday,3/3/2021 9:17:37 AM
EYEN,45 Stocks Moving In Tuesday's Mid-Day Session,3/2/2021 6:08:58 PM
EYEN,Eyenovia to Host Key Opinion Leader Webinar on Presbyopia,2/16/2021 2:00:00 PM
EYEN,"The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts",2/11/2021 1:26:22 PM
EYEN,"The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs",2/10/2021 1:34:43 PM
EYEN,"The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations",1/13/2021 1:25:38 PM
EYEN,"The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue",1/12/2021 2:15:54 PM
EYEN,"The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration",1/7/2021 2:20:50 PM
EYEN,Eyenovia to Participate in Presbyopia Panel Discussion at the LifeSci Partners 10th Annual Corporate Access Event,1/6/2021 2:00:00 PM
EYEN,Eyenovia Announces NDA Submission For MydCombi - Quick Facts ,12/29/2020 1:18:06 PM
EYEN,"The Week Ahead In Biotech (Dec. 27-Jan. 2): Data Releases, Regulatory Filings To Move Stocks",12/26/2020 3:15:52 PM
EYEN,Dosing underway in Eyenovia's late-stage Microline study for presbyopia,12/16/2020 12:31:21 PM
EYEN,Eyenovia on go with late-stage study with pilocarpine formulation in presbyopia,12/3/2020 12:31:50 PM
EYEN,Eyenovia Reports Third Quarter 2020 Financial Results,11/10/2020 10:06:00 PM
EYEN,"Eyenovia to Report Third Quarter 2020 Results on Tuesday, November 10",11/5/2020 2:00:00 PM
EYEN,Eyenovia to Host Investor Call to Discuss Recent Licensing Agreements Resulting in Total Potential License Payments and Development Cost Reimbursement and Savings of Approximately $100 Million,10/13/2020 1:00:10 PM
EYEN,Bausch Health Acquires License For Investigational Atropine Ophthalmic Solution ,10/12/2020 1:11:46 PM
EYEN,Eyenovia to Present at the 22nd Annual H.C. Wainwright Global Investment Conference,9/9/2020 2:30:10 PM
EYEN,"Eyenovia, Inc. Announces Underwriters’ Full Exercise of Over-Allotment Option in Public Offering",8/24/2020 2:30:10 PM
EYEN,"Eyenovia, Inc. Announces Closing of Offering of Common Stock",8/21/2020 10:05:10 PM
EYEN,"Eyenovia, Inc. Prices Public Offering of Common Stock",8/19/2020 3:10:10 PM
EYEN,"Eyenovia, Inc. Announces Proposed Public Offering of Common Stock",8/18/2020 10:03:11 PM
EYEN,Eyenovia Reports Second Quarter 2020 Financial Results,8/12/2020 10:05:10 PM
EYEN,Eyenovia News: Why EYEN Stock Is Skyrocketing 33% Today,8/11/2020 6:20:12 PM
EYEN,Eyenovia Announces Conference Call and Webcast for Second Quarter 2020 Financial Results,7/29/2020 2:30:10 PM
EYEN,"AUPH Faces FDA In Jan, ARCT To Advance LUNAR-COV19 Vaccine, IFRX On Watch, All Eyes On ALEC ",7/22/2020 8:41:45 AM
EYEN,Eyenovia Resumes Recruitment of Phase III CHAPERONE Study for Progressive Myopia,6/30/2020 10:05:10 PM
EYEN,"Eyenovia, Inc. Announces Adjournment of 2020 Annual Meeting of Stockholders to June 30, 2020  and Change to a Virtual Meeting Format",6/11/2020 10:10:10 PM
EYEN,"Eyenovia Announces Intention to Adjourn 2020 Annual Meeting of Stockholders to June 30, 2020 and Change to a Virtual Meeting Format",6/5/2020 10:10:10 PM
EYEN,Eyenovia Reports First Quarter 2020 Financial Results,5/13/2020 10:05:10 PM
EYEN,Eyenovia Announces Conference Call and Webcast for First Quarter 2020 Financial Results,5/6/2020 2:30:10 PM
EYEN,Eyenovia Reports Fourth Quarter and Full Year 2019 Financial Results,3/25/2020 9:05:00 PM
EYEN,"Eyenovia, Inc. Announces Closing of Approximately $6.0 Million Private Placement",3/24/2020 10:10:00 PM
EYEN,"Eyenovia, Inc. Announces Approximately $6.0 Million Private Placement",3/23/2020 11:35:00 PM
EYEN,Eyenovia Announces Conference Call and Webcast for Fourth Quarter and Full-Year 2019 Financial Results,3/11/2020 1:30:00 PM
EYEN,Eyenovia to Participate in Two Upcoming Investor Conferences,3/4/2020 2:30:00 PM
EYEN,Eyenovia Expands Scientific Advisory Board with Two Experts in Optometry,12/19/2019 2:30:00 PM
EYEN,Eyenovia Reports Third Quarter 2019 Financial Results,11/13/2019 10:05:00 PM
EYEN,Eyenovia Announces Conference Call and Webcast for Third Quarter 2019 Financial Results,10/31/2019 1:30:05 PM
EYEN,Eyenovia Advances MicroLine for the Treatment of Presbyopia Towards Phase III Development and Reprioritizes Late-Stage Ophthalmology Pipeline,10/29/2019 9:05:05 PM
EYEN,Eyenovia to Participate in Multiple Upcoming Medical Meetings,10/2/2019 2:30:00 PM
EYEN,"6 Top Gainers In Healthcare Sector (ACAD, ARDX, KOOL…) ",9/10/2019 4:51:18 AM
EYEN,Eyenovia to Present at Two Upcoming Investor Conferences,9/3/2019 2:30:00 PM
EYEN,Eyenovia Reports Second Quarter 2019 Financial Results,8/12/2019 10:05:00 PM
EYEN,Eyenovia Announces Conference Call and Webcast for Second Quarter 2019 Financial Results,8/6/2019 2:30:00 PM
EYEN,"Eyenovia, Inc. Announces Underwriters’ Full Exercise of Over-Allotment Option in Public Offering",7/16/2019 10:05:00 PM
EYEN,"Eyenovia, Inc. Announces Closing of Public Offering",7/15/2019 10:30:00 PM
EYEN,"Eyenovia, Inc. Prices Public Offering of Common Stock",7/11/2019 3:00:00 PM
EYEN,"Eyenovia, Inc. Announces Proposed Public Offering of Common Stock",7/10/2019 10:07:00 PM
EYEN,Eyenovia Enrolls First Patient in Phase III CHAPERONE Study for Progressive Myopia,6/4/2019 2:30:00 PM
EYEN,Eyenovia Reports First Quarter 2019 Financial Results,5/14/2019 12:30:00 PM
EYEN,Eyenovia Announces Presentation of Successful Phase 3 Studies at the ASCRS-ASOA Annual Meeting,5/6/2019 2:30:00 PM
EYEN,Eyenovia Announces Conference Call and Webcast for First Quarter 2019 Financial Results,5/1/2019 2:30:00 PM
EYEN,Eyenovia Reports Fourth Quarter and Full Year 2018 Financial Results,3/27/2019 11:30:00 AM
EYEN,Eyenovia Announces Conference Call and Webcast for Fourth Quarter and Full-Year 2018 Financial Results,3/13/2019 1:30:00 PM
EYEN,Eyenovia to Participate in Two Upcoming Investor Conferences,3/4/2019 2:30:00 PM
EYEN,Eyenovia Announces Confirmatory Results from Second MicroStat Phase III Registration Study for Mydriasis,2/25/2019 2:30:00 PM
EYEN,"8 Top Gainers In Healthcare Sector (LMAT, CLSD, LNTH...) ",2/21/2019 2:31:56 AM
EYEN,Eyenovia confirms expanded MicroProst Phase III indication to enroll broad patient population for IOP lowering,2/13/2019 2:30:00 PM
EYEN,Eyenovia Announces FDA Acceptance of IND Application for MicroPine  to Reduce the Progression of Myopia,2/6/2019 2:30:00 PM
EYEN,"7 Top Gainers In Healthcare Sector (ALRN, APHA, INSY...) ",2/5/2019 2:41:41 AM
EYEN,"5 Top Gainers In Healthcare Sector (CODX, SXTC, TMDI...) ",1/31/2019 2:21:44 AM
EYEN,"What's Making News At Roche, EYEN, STML, Sirona, TRVN? ",1/30/2019 1:48:18 PM
EYEN,Eyenovia Prices Public Offering of Common Stock,12/19/2018 3:05:00 PM
EYEN,Eyenovia Completes Patient Enrollment in MicroStat MIST-1 Study and Enrolls First Patient in MIST-2 Study,12/3/2018 3:00:00 PM
EYEN,Eyenovia Announces Publication of its PG21 Phase II Trial Results Demonstrating Robust IOP Lowering Effect and Patient Usability,11/28/2018 10:05:00 PM
EYEN,Eyenovia Initiates Phase III MicroStat Program for Pharmacologic Mydriasis: Enrolls First Patient in MIST-1 Study,11/26/2018 3:00:00 PM
EYEN,Eyenovia Announces FDA Acceptance of MicroStat IND Application for Mydriasis,11/13/2018 1:30:00 PM
EYEN,Eyenovia Announces Conference Call and Webcast for Third Quarter 2018 Financial Results,11/1/2018 1:30:00 PM
EYEN,Eyenovia to Present at the Ophthalmology Innovation Summit at the American Academy of Ophthalmology 2018,10/23/2018 3:00:00 PM
EYEN,Eyenovia to Participate in Panel Presentation at OSN New York 2018,9/19/2018 2:30:00 PM
EYEN,Eyenovia to Present at the Ladenburg Thalmann 2018 Healthcare Conference,9/18/2018 1:30:00 PM
EYEN,Eyenovia to Present at the 20th Annual H.C. Wainwright Global Investment Conference,8/21/2018 1:30:00 PM
EYEN,Eyenovia Reports Second Quarter 2018 Financial Results,8/14/2018 12:30:00 PM
EYEN,Eyenovia’s EYN PG21 Trial Evaluating High-Precision Microdose of Latanoprost Demonstrates Robust Intraocular Pressure Lowering and Patient Usability,8/13/2018 2:30:00 PM
EYEN,Eyenovia Announces Conference Call and Webcast for Second Quarter 2018 Financial Results,7/31/2018 2:30:00 PM
EYEN,"GENE To Roll Out New Tests, DARE Rises On CatSper Deal, ADXS Back On Track ",7/17/2018 3:13:34 AM
EYEN,"MBVX Nears D Day, BNTC Soars On AXON Deal, DEPO Catches Eyes, APEN Up 47% YTD ",7/10/2018 4:06:46 AM
EYEN,Eyenovia Appoints Michael Rowe as Vice President of Marketing Ahead of Initiation of Multiple Phase III Programs,7/9/2018 1:30:00 PM
EYEN,Eyenovia to Present at the JMP Securities 2018 Life Sciences Conference,6/11/2018 1:30:00 PM
EYEN,Eyenovia Receives Notices of Allowance from USPTO on Two Additional Patent Applications for Ophthalmic Drug Delivery,6/5/2018 1:30:00 PM
EYEN,BRIEF-Eyenovia Reports Q1 Loss Per Share Of $0.45,5/9/2018 12:34:27 PM
EYEN,Eyenovia Announces Conference Call and Webcast for First Quarter 2018 Financial Results,4/19/2018 2:30:00 PM
EYEN,BRIEF-Eyenovia Reports Q4 Loss Per Share $0.84,4/2/2018 2:58:11 PM
EYEN,Eyenovia Appoints Three Industry Veterans to Board of Directors,3/26/2018 10:05:00 PM
EYEN,Eyenovia Announces Conference Call and Webcast for Fourth Quarter and Full Year 2017 Financial Results,3/19/2018 1:30:00 PM
EYEN,Eyenovia to Present at the 30th Annual ROTH Conference,2/27/2018 2:30:00 PM
EYEN,Eyenovia Advances MicroPine for Myopia into Phase III Clinical Development and Appoints Stanford Professor Dr. Douglas Fredrick to its Scientific Advisory Board and Myopia Program Steering Committee,2/21/2018 2:30:00 PM
EYEN,Eyenovia Announces Closing of $27.3 Million Initial Public Offering,1/29/2018 10:05:00 PM
